Search
for

    Learn

    5 / 22 results

      learn GT20029

      research compound made to degrade androgen receptors in scalp

      learn HMI-115

      much-hyped research compound targeting prolactin receptor in scalp

      learn RU58841

      a potent but unapproved and potentially problematic topical anti-androgen

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Having androgen receptor density and sensitivity at wrong f*ing place

      in Satire  7 upvotes 1 year ago
      The conversation discusses hair loss treatments, focusing on the use of topical minoxidil, microneedling, finasteride, and dutasteride, while debating the role of testosterone and DHT in hair loss. It also touches on the potential liver health impacts of these treatments and the genetic sensitivity of hair follicles to androgens.

      community Kintor develop GT20026 Anti-Androgen receptor drug with NO SIDES

      in Treatment  18 upvotes 5 years ago
      The conversation discusses GT20029, a new topical drug for hair loss and acne without notable side effects, which has been accepted for investigational use in China. Some users express skepticism about the legitimacy of the company and the potential for other drugs like RU58841 to be developed due to patent expiration and lack of profitability.

      community Difference: GT20029 vs CosmeRNA

      in Treatment  10 upvotes 2 years ago
      GT20029 and CosmeRNA are both potential hair loss treatments; GT20029 breaks down the androgen receptor, while CosmeRNA prevents its production. Continuous use is needed, but less frequently than current treatments like Minoxidil and Finasteride.